Provided by Tiger Trade Technology Pte. Ltd.

Henry Schein

85.04
-1.7300-1.99%
Post-market: 85.040.00000.00%19:30 EDT
Volume:1.80M
Turnover:153.57M
Market Cap:9.44B
PE:24.79
High:87.10
Open:87.01
Low:84.15
Close:86.77
52wk High:92.18
52wk Low:61.95
Shares:111.00M
Float Shares:94.38M
Volume Ratio:1.60
T/O Rate:1.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.43
EPS(LYR):3.27
ROE:8.85%
ROA:4.39%
PB:2.99
PE(LYR):26.01

Loading ...

Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Insulet (PODD) and Gilead Sciences (GILD)

TIPRANKS
·
May 14

Ananym urges BWX Technologies to commercialize reactor design, says shares could double

Reuters
·
May 13

Henry Schein Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 12

Henry Schein posts transcript of Q1 2026 earnings call

Reuters
·
May 12

Henry Schein, Inc. Just Recorded A 8.1% EPS Beat: Here's What Analysts Are Forecasting Next

Simply Wall St.
·
May 08

Henry Schein Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 08

Henry Schein price target lowered to $85 from $87 at UBS

TIPRANKS
·
May 07

Henry Schein Is Maintained at Neutral by UBS

Dow Jones
·
May 07

Henry Schein Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
May 07

Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT), Henry Schein (HSIC) and Exelixis (EXEL)

TIPRANKS
·
May 06

Henry Schein Inc : Leerink Partners Cuts Target Price to $83 From $87

THOMSON REUTERS
·
May 06

Henry Schein Earnings Call Highlights Margin Momentum

TIPRANKS
·
May 06

Jefferies Adjusts Price Target on Henry Schein to $80 From $89, Maintains Hold Rating

MT Newswires Live
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel

Reuters
·
May 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Henry Schein (HSIC), Viridian Therapeutics (VRDN) and Q32 Bio (QTTB)

TIPRANKS
·
May 05

Henry Schein Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Henry Schein Says 2026 Guidance Assumes Stable Dental, Medical End Markets; FX Rates Stay Near Current Levels - Conf Call

THOMSON REUTERS
·
May 05

Henry Schein Says 2026 Outlook Assumes Tariff, Higher Oil-Price Impact Can Be Mitigated; Taking Steps to Offset Oil-Driven Freight, Pricing Pressure - Conf Call

THOMSON REUTERS
·
May 05

Henry Schein Exec Says Qtr Hit by Lower Demand for Point-of-Care Respiratory Diagnostic Tests After Light Flu Season - Conf Call

THOMSON REUTERS
·
May 05

Henry Schein reaffirms 2026 non-GAAP EPS forecast of USD 5.23-5.37

Reuters
·
May 05